It has been documented that both histaminergic and GABAergic systems participate in the neurobiology of anxiety behaviour. In the current research, we investigated the effects of the histaminergic system and GABA A receptor agents on anxietyrelated behaviours and their interaction using the elevated plus maze test in mice.Intraperitoneal (I.P.) administration of muscimol (0.12 and 0.25 mg/kg) increased the open arm time (OAT) (P < 0.001) without affecting the open arm entries (OAE) and locomotor activity, showing an anxiolytic effect. I.P. injection of bicuculline (0.5 and 1 mg/kg) decreased OAT (P < 0.001) but not OAE and locomotor activity, suggesting an anxiogenic behaviour. Intracerebroventricular (I.C.V.) microinjection of histamine (2.5 and 5 μg/mouse) resulted in a decline in OAT (P < 0.001) but not OAE and locomotor activity, indicating an anxiogenic response. Co-administration of histamine with GABAergic agents, muscimol (0.06 mg/kg; I.P.) and bicuculline (0.25 mg/kg; I.P.), decreased (P < 0.001) and increased (P < 0.05), respectively, the anxiogeniclike response to the effective dose (5 μg/mouse; I.C.V.) of histamine. In addition, cotreatment of effective doses of histamine (2.5 and 5 μg/mouse;I.C.V.) with an effective dose of muscimol (0.12 mg/kg; I.P.) and a non-effective dose of bicuculline (0.25 mg/kg; I.P.) significantly decreased OAT (P < 0.001), suggesting a likely interaction between the histaminergic and GABAergic systems in the regulation of anxiety. The results demonstrated a synergistic anxiogenic-like effect between histamine and bicuculline in mice. In conclusion, our results present an interaction between the histaminergic and GABAergic systems in anxiolytic/anxiogenic-like behaviours in the elevated plus maze test.